1. Home
  2. EXPO vs CPRX Comparison

EXPO vs CPRX Comparison

Compare EXPO & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Exponent Inc.

EXPO

Exponent Inc.

HOLD

Current Price

$67.65

Market Cap

3.4B

ML Signal

HOLD

Logo Catalyst Pharmaceuticals Inc.

CPRX

Catalyst Pharmaceuticals Inc.

HOLD

Current Price

$23.18

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPO
CPRX
Founded
1967
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.4B
3.0B
IPO Year
1996
2006

Fundamental Metrics

Financial Performance
Metric
EXPO
CPRX
Price
$67.65
$23.18
Analyst Decision
Buy
Strong Buy
Analyst Count
3
1
Target Price
$90.50
$35.00
AVG Volume (30 Days)
461.8K
1.1M
Earning Date
01-01-0001
01-01-0001
Dividend Yield
1.78%
N/A
EPS Growth
N/A
28.24
EPS
2.07
1.68
Revenue
$582,014,000.00
$119,072,803.00
Revenue This Year
$12.61
$8.00
Revenue Next Year
$8.00
$9.77
P/E Ratio
$33.60
$13.91
Revenue Growth
4.21
16.39
52 Week Low
$63.81
$19.05
52 Week High
$84.00
$26.56

Technical Indicators

Market Signals
Indicator
EXPO
CPRX
Relative Strength Index (RSI) 37.93 41.69
Support Level $64.70 $22.46
Resistance Level $73.22 $24.86
Average True Range (ATR) 2.21 0.97
MACD -0.36 -0.11
Stochastic Oscillator 9.87 28.16

Price Performance

Historical Comparison
EXPO
CPRX

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About CPRX Catalyst Pharmaceuticals Inc.

Catalyst Pharmaceuticals Inc is a commercial-stage, patient-centric biopharmaceutical company focused on in-licensing, developing, and commercializing novel high-quality medicines for patients living with rare and difficult to treat diseases. The Company sells three commercial stage drug products, FIRDAPSE (amifampridine), AGAMREE (vamorolone), and FYCOMPA (perampanel). The Company is currently seeking to further expand its product portfolio, with a focus on acquiring the rights to immediately and near-term accretive assets to treat rare (orphan) diseases across therapeutic areas, including clinical-stage opportunities with established proof of concept.

Share on Social Networks: